TKR: Tourniquet use increases pain and reduces range of motion .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(11):53 Acta Orthop. 2012 Oct;83(5):499-503. doi: 10.3109/17453674.2012.727078. Epub 2012 Sep 14.50 patients undergoing total knee arthroplasty were included in this trial to determine the effect of tourniquet use on implant migration. Patients were randomized to undergo cemented total knee arthroplasty with or without the use of a tourniquet. The results of this study indicate that the use of a tourniquet did not reduce implant migration, caused more postoperative pain, and reduced range of motion.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Yes = 1
Uncertain = 0.5
Not Relevant = 0
No = 0
The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.
3/4
Randomization
3/4
Outcome Measurements
3/4
Inclusion / Exclusion
4/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.
Why was this study needed now?
Tourniquets are routinely used during total knee replacement to reduce bleeding which might impair fixation of the cemented prosthesis. However, tourniquet use is associated with re-perfusion trauma, oxidative stress, deep vein thrombosis risk, and injury due to pressure on skin, muscles, nerves, and arteriosclerotic vessels. Tourniquets may also reduce the surgical field, which may lead to a number of other complications and jeopardize the sterility of the postoperative dressing. This study aimed to determine the effects of tourniquet use on patients undergoing cemented total knee arthroplasty.
What was the principal research question?
Does tourniquet use reduce postoperative migration and improve clinical outcomes in patients, 2 years after undergoing cemented total knee arthroplasty?
- The difference in migration, between the patients who received a tourniquet and the patients who did not, was not significant: 0.01 mm (95% CI: -0.13 to 0.15).
- The patients who received a tourniquet experienced significantly more pain during the first 4 postoperative days than the patients who did not receive and tourniquet (49 mm versus 41 mm; p=0.01).
- Tourniquet use significantly reduced total overt bleeding when compared to no tourniquet use (317 mL versus 615 mL; p=0.002), but did not significantly reduce the total bleeding estimated by hemoglobin dilution (1184 mL versus 1236 mL).
- There was no significant difference in morphine consumption between the patients who received a tourniquet and the patients who did not receive a tourniquet.
- The mean range of motion at 2 years for the patients in the tourniquet group was 113 degrees, whereas the mean range of motion for the patients in the control group was 124 degrees (p=0.001).
What should I remember most?
Tourniquet use did not significantly alter migration of the cemented total knee arthroplasty and may cause significantly more postoperative pain and reduce range of motion when compared to no tourniquet use.
How will this affect the care of my patients?
It is still unclear if tourniquet use during total knee arthroplasty is efficacious. Although its use can reduce operative blood loss, it may effect implant fixation/migration, postoperative pain and range of motion. Further randomized trials are needed to determine if tourniquet use has any effect on implant fixation and migration, and if any differences detected have a clinically significant impact on long-term outcomes.
DISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
0 of 4 monthly FREE articles unlocked
